| Code | CSB-MP002061HU1 |
| Abbreviation | Recombinant Human KITLG protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Kit ligand drives the survival, proliferation, and differentiation of hematopoietic progenitors and mast cells through c-Kit receptor engagement, making it indispensable for studies of hematopoiesis, mast cell biology, and stem cell niche signaling. This recombinant human KITLG, spanning residues 26–189 and expressed in mammalian cells to preserve native glycosylation, demonstrates an ED50 of 1.813–3.203 ng/mL in MO7e cell proliferation assays, confirming potent receptor activation suitable for dose-response studies in TF-1 cells, primary hematopoietic progenitors, and mast cell differentiation protocols. The low endotoxin level (< 1.0 EU/μg) and > 95% purity meet the quality thresholds commonly required for immune cell functional assays, where LPS contamination would confound cytokine-specific responses, and support use in JAK/STAT and MAPK signaling pathway analyses. Researchers can apply this protein as a positive control in ELISA-based cytokine detection platforms or as an immunogen for antibody development targeting the soluble Kit ligand isoform.
There are currently no reviews for this product.